VBIV

VBI Vaccines, Inc. New Common Stock (Canada)
VBIV

Overview Fund Activity
Delisted

VBIV was delisted on the 7th of August, 2024.

Back to rankings

37 hedge funds and large institutions have $1.9M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 14 closing their positions.

Holders
37
Holders Change
-9
Holders Change %
-19.57%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
8
Closed
14
Calls
$672K
Puts
$2K
Net Calls
+$670K
Net Calls Change
+$140K

Top Buyers

1
Alyeska Investment Group
1
Alyeska Investment Group
Illinois
$464K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$92.4K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$18K
4
AGM
4
Alpine Global Management
New York
$16.7K
5
HF
5
HRT Financial
New York
$15K

Top Sellers

1
YIH
1
Y-Intercept (HK)
Hong Kong
$0
2
Charles Schwab
2
Charles Schwab
California
$0
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
Jane Street
4
Jane Street
New York
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$23.3K
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
51
Concourse Financial Group Securities
Alabama
– – – –
Citadel Advisors
52
Citadel Advisors
Florida
– – – –
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
$0 1,354 +54 +4%
HFS
54
Hantz Financial Services
Michigan
$0 750 +700 +1,400%
1 2
3